Independent coordination and strategic support for biotech teams developing
vaccines, biologics, and anti-infectives.
InVivoBridge designs and coordinates multi-site in vivo studies, aligning
scientific goals, partners, and regulatory requirements.
We act as your strategic preclinical partner ensuring clarity, speed, and
compliance across every study phase.
InVivoBridge supports biotech innovators by connecting scientific vision with
operational execution.
From study design to data integration, we streamline preclinical projects
through structured coordination and expert oversight.
Preclinical roadmap planning,
partner matching, model selection,
and endpoint definition.
Cross-site execution oversight,
communication tracking, and
milestone management.
Guidance for ethics submissions
under EU Directive 2010/63,
Paragraph 44 (DE), and Article 9
(NL).
Consolidation of CRO + academic
results into investor-ready reports.
formats tailored to your study needs.
One coordinated study phase or full preclinical package.
Multi-month execution management across partners.
Strategic review and translational insight on study design.
Let’s align science, strategy, and execution to accelerate your next in vivo program efficiently and compliantly across Europe.
Study Coordination
Regulatory Support
CRO + Academic Collaboration
Integrated Reporting
Immunology Model Access